Search

everythinglearnresearchcommunity

for

Search:↓

Post-finasteride syndrome causes lasting sexual, mental, and physical issues, needing more research for solutions.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

Alopecia should be treated as a medical condition because it may increase the risk of serious diseases and psychological issues.

High uric acid can cause health problems, but lifestyle changes can help manage it.

Medications for benign prostatic syndrome can cause cognitive issues and depression.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Serum triglyceride levels are not linked to prostate cancer risk.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Thermobalancing Therapy can treat enlarged prostate and improve men's quality of life.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

Certain medications can reduce sexual desire and function, especially in women.

Shorter PSADT after prostate surgery is linked to higher risk of death.

A castrated dog developed hair loss and prostate issues from long-term exposure to estrogen cream.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Urban living may increase prostate cancer risk, while early sexual activity might reduce it.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.